Membership Scheme Changes from 2022
EMQN have recently undergone an organisational review, and as a result our membership scheme is evolving and adapting to fit in with both the needs of our members and our organisation. From 2022, we will be offering our membership at no yearly cost.
Click below to read EMQN’s full statement on our membership scheme changes!
We are a not-for-profit organisation promoting quality in genomic testing by establishing, harmonising and disseminating best practice.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
EQAs for SARS-Cov-2 and other respiratory viruses open for registration
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
The latest news and press releases
The 2022 Provisional ILRs have been Published: Germline EQAs - https://t.co/a9QjsKShx7
Opportunities available: Are you interested in sharing good practice and improving the quality of diagnostic genomi… https://t.co/JLH6BRfgGU
Are you ready for the new In-vitro Diagnostics (EU) Regulation (IVDR)? FREE Webinar from the European Society of Hu… https://t.co/Jnr7TO9qlk
Final Results Published for 2021 NGS (v Germline) EQA - https://t.co/NTIXVFMHfD
Final Results Published: 2021 Ovarian, Breast, Prostate and Pancreatic Cancer (v Germline) and Ovarian Cancer (v So… https://t.co/heGzxBrrYE